The origin of neointimal smooth muscle cells in transplant arteriosclerosis from recipient bone-marrow cells in rat aortic allograft

Abstract

In order to investigate the origin of neointimal smooth muscle cells in transplant arteriosclerosis in rat aortic allograft, sex-mismatched bone marrow transplantation was performed from male Wistar rats to female Wistar rats. Four weeks after transplantation, the aortic transplant model was established by means of micro-surgery in rats. The recipients were divided into 4 groups: female Wistar-female Wistar aortic isografts, female SD female Wistar aortic allografts, male SD-male Wistar aortic allografts, female SD-chimera Wistar aortic allografts. Eight weeks after transplantation, aortic grafts were removed at autopsy and processed for histological evaluation and immunohistochemistry. The results indicated that excessive accumulation of α-SMA-positive smooth muscle cells resulted in significant neointima formation and vascular lumen stricture in rat aortic allografts. Neointima assay revealed that the neointimal area and NIA/MA ratio of transplanted artery were significantly increased in all of aortic allograft groups as compared with those in aortic isograft group (P<0.01). Neointimal smooth muscle cells were harvested from cryostat sections of aortic allograft by microdissection method. The Sry gene-specific PCR was performed, and the result showed that a distinct DNA band of 225 bp emerged in the male-male aortic allograft group and chimera aortic allograft group respectively, but not in the female-female aortic allograft group. It was suggested that recipient bone-marrow cells, as the origin of neointimal smooth muscle cells, contributed to the pathological neointimal hyperplasia of aortic allograft and transplant arteriosclerosis.

Keywords

chronic rejection / aortic transplant / neointimal hyperplasia / smooth muscle cells / bone-marrow cells

References

[1] SayeghM. H., CarpenterC. B.. Transplantation 50 Years Later—Progress, Challenges, and Promises. N Engl J Med, 2004, 351(26): 2761-2766

[2] LechlerR. I., SykesM., ThomsonA. W., et al.. Organ transplantation—how much of the promise has been realized?. Nat Med, 2005, 11(6): 605-613

[3] JoostenS. A., SijpkensY. W., van KootenC., et al.. Chronic renal allograft rejection: pathophysiologic considerations. Kidney Int, 2005, 68(1): 1-13

[4] ZalewskiA., ShiY., JohnsonA. G.. Diverse origin of intimal cells: smooth muscle cells, myofibroblasts, fibroblasts, and beyond?. Circ Res, 2002, 91(8): 652-655

[5] SongZ. F., ZhengQ. C., ShuX. G., et al.. The study on the potentiation of recipient cells involved in neointimal hyperplasia in rat aortic allograft. Chin J Exp Surg (Chinese), 2006, 23(4): 534-536

[6] LibbyP., PoberJ. S.. Chronic rejection. Immunity, 2001, 14(4): 387-397

[7] JoostenS. A., van KootenC., PaulL. C.. Pathogenesis of chronic allograft rejection. Transpl Int, 2003, 16(3): 137-145

[8] ReligaP., BojakowskiK., BojakowskaM., et al.. Allogenic immune response promotes the accumulation of host-derived smooth muscle cells in transplant arteriosclerosis. Cardiovasc Res, 2005, 65(2): 535-545

[9] SinclairA. H., BertaP., PalmerM. S., et al.. A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature, 1990, 346(6281): 240-244

[10] BradburyM. W., IsolaL. M., GordonJ. W.. Enzymatic amplification of a Y chromosome repeat in a single blastomere allows identification of the sex of preimplantation mouse embryos. PNAS, 1990, 87(11): 4053-4057